Press release
Future Perspectives: Key Trends Shaping the Chronic Disease Management Market Up to 2030
Chronic Disease Management Market
Steady Growth Expected in the Chronic Disease Management Market Size Through 2030
The chronic disease management market is forecasted to experience robust growth, reaching a valuation of $29.55 billion by 2030. This surge corresponds to an impressive compound annual growth rate (CAGR) of 21.1%. Several factors are driving this expansion, including the rising preference for value-based care models, greater adoption of remote patient monitoring technologies, the proliferation of cloud-based healthcare platforms, and an increasing emphasis on patient engagement tools. Additionally, growing investments in digital health ecosystems are crucial contributors to market development. Key trends shaping this growth include the integration of AI-powered patient monitoring tools, expanded use of remote care management platforms, enhanced incorporation of data analytics for disease tracking, broader implementation of personalized care management programs, and intensified focus on preventive care workflows.
Download a free sample of the chronic disease management market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR
Leading Companies Shaping the Chronic Disease Management Market
Several prominent organizations dominate the chronic disease management landscape, including Veradigm Inc., ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, EXLService Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Healthy.io, Optum Inc., and Omada Health.
Significant Acquisition Boosting Market Positioning
In February 2025, Teladoc Health, a US-based virtual care and chronic-condition platform provider, acquired Catapult Health for an undisclosed sum. This strategic move is designed to enhance Teladoc's capabilities in chronic condition management and at-home diagnostics, strengthening its ecosystem focused on monitoring, prevention, and home-based healthcare services. Catapult Health, also from the US, delivers preventive healthcare and workplace checkups, including virtual consultations and diagnostic laboratory services. This acquisition aligns with the increasing demand for comprehensive digital chronic care services.
View the full chronic disease management market report:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR
Cutting-Edge Trends Driving Innovation in Chronic Disease Management
Industry leaders are focusing on developing sophisticated integrated digital care platforms that combine remote monitoring, personalized coaching, and data analytics to boost patient engagement and improve treatment adherence. These platforms support better health outcomes by enabling continuous, tailored care. For instance, in January 2024, Amazon partnered with Omada Health, a US-based digital health provider, to launch a thorough chronic condition management program. This initiative offers ongoing support for patients with diabetes, hypertension, and heart disease by integrating real-time health tracking, virtual coaching, and customized care plans. By leveraging connected care solutions and data insights, this program empowers patients, aids clinical decisions, and enhances long-term health results.
Detailed Segmentation of the Chronic Disease Management Market
The chronic disease management market is segmented across several categories to facilitate tailored approaches:
1) By Service Type:
- Consulting Services
- Implementation Services
- Educational Services
2) By Delivery Mode:
- On-premise
- Cloud-based
- Web-based
3) By Disease Type:
- Cardiovascular Diseases
- Diabetes
- Cancer
- Asthma
- Chronic Obstructive Pulmonary Disorders
4) By End User:
- Providers
- Payers
Additional Subdivisions Include:
- Consulting Services: Disease Management Assessment, Program Design and Development, Performance Evaluation
- Implementation Services: Technology Integration, Workflow Optimization, Care Coordination
- Educational Services: Patient Education Programs, Provider Training, Community Awareness Initiatives
This comprehensive segmentation highlights the diverse components and service models that characterize the chronic disease management market and support its rapid evolution.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future Perspectives: Key Trends Shaping the Chronic Disease Management Market Up to 2030 here
News-ID: 4504783 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
